164 related articles for article (PubMed ID: 15686922)
41. Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
Popovici-Muller J; Shipps GW; Rosner KE; Deng Y; Wang T; Curran PJ; Brown MA; Siddiqui MA; Cooper AB; Duca J; Cable M; Girijavallabhan V
Bioorg Med Chem Lett; 2009 Nov; 19(22):6331-6. PubMed ID: 19819138
[TBL] [Abstract][Full Text] [Related]
42. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
43. Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro.
Koev G; Dekhtyar T; Han L; Yan P; Ng TI; Lin CT; Mo H; Molla A
Antiviral Res; 2007 Jan; 73(1):78-83. PubMed ID: 16945431
[TBL] [Abstract][Full Text] [Related]
44. Effects of new quinizarin derivatives on both HCV NS5B RNA polymerase and HIV-1 reverse transcriptase associated ribonuclease H activities.
Tramontano E; Kharlamova T; Zinzula L; Esposito F
J Chemother; 2011 Oct; 23(5):273-6. PubMed ID: 22005058
[TBL] [Abstract][Full Text] [Related]
45. Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.
Bennett F; Kezar HS; Girijavallabhan V; Huang Y; Huelgas R; Rossman R; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Clark JL; Fowler AT; Geng F; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; George Njoroge F; Arasappan A
Bioorg Med Chem Lett; 2012 Aug; 22(15):5144-9. PubMed ID: 22814211
[TBL] [Abstract][Full Text] [Related]
46. Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide.
Herschhorn A; Oz-Gleenberg I; Hizi A
Biochemistry; 2008 Jan; 47(1):490-502. PubMed ID: 18052256
[TBL] [Abstract][Full Text] [Related]
47. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
[TBL] [Abstract][Full Text] [Related]
48. Use of 3D QSAR methodology for data mining the National Cancer Institute Repository of Small Molecules: application to HIV-1 reverse transcriptase inhibition.
Gussio R; Pattabiraman N; Kellogg GE; Zaharevitz DW
Methods; 1998 Mar; 14(3):255-63. PubMed ID: 9571082
[TBL] [Abstract][Full Text] [Related]
49. Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases.
Gagnon A; Amad MH; Bonneau PR; Coulombe R; DeRoy PL; Doyon L; Duan J; Garneau M; Guse I; Jakalian A; Jolicoeur E; Landry S; Malenfant E; Simoneau B; Yoakim C
Bioorg Med Chem Lett; 2007 Aug; 17(16):4437-41. PubMed ID: 17583503
[TBL] [Abstract][Full Text] [Related]
50. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
51. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
Tsantrizos YS
Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
[TBL] [Abstract][Full Text] [Related]
52. [Development of Bio-active Fullerene Derivatives Suitable for Drug].
Mashino T
Yakugaku Zasshi; 2022; 142(2):165-179. PubMed ID: 35110453
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and antiviral activity of highly water-soluble polycarboxylic derivatives of [70]fullerene.
Kornev AB; Peregudov AS; Martynenko VM; Balzarini J; Hoorelbeke B; Troshin PA
Chem Commun (Camb); 2011 Aug; 47(29):8298-300. PubMed ID: 21666897
[TBL] [Abstract][Full Text] [Related]
54. [HIV reproduction inhibition by amino acid and dipeptide derivatives of fullerene C60].
Miller GG; Romanova VS; Pokidysheva LN; Titova IV; Kaliberda EN; Rumsh LD; Andreeva OI; Rybalkin NP
Antibiot Khimioter; 2004; 49(12):3-8. PubMed ID: 16050493
[TBL] [Abstract][Full Text] [Related]
55. Fullerene sugar balls: a new class of biologically active fullerene derivatives.
Nierengarten I; Nierengarten JF
Chem Asian J; 2014 Jun; 9(6):1436-44. PubMed ID: 24678063
[TBL] [Abstract][Full Text] [Related]
56. [Polymethylene derivatives of nucleic bases with omega-functional groups. Pyrimidine derivatives].
Makinskiĭ AA; Kritsyn AM; Ul'ianova EA; Zakharova OD; Nevinskiĭ GA
Bioorg Khim; 2000 Oct; 26(10):735-42. PubMed ID: 11221254
[TBL] [Abstract][Full Text] [Related]
57. [Decrease in RNA-dependent DNA polymerase activity of recombinant human immunodeficiency virus reverse transcriptase in bidistilled modified water].
Shvetsov IuP; Novikov VV; Fesenko EE; Aliushev FK; Eremin SM; Markov IA; Ten IuA
Biofizika; 2001; 46(2):379-80. PubMed ID: 11357356
[TBL] [Abstract][Full Text] [Related]
58. Antiviral therapy targeting viral polymerase.
Tsai CH; Lee PY; Stollar V; Li ML
Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
[TBL] [Abstract][Full Text] [Related]
59. Deformation density components analysis of fullerene-based anti-HIV drugs.
Fakhraee S; Souri M
J Mol Model; 2014 Nov; 20(11):2486. PubMed ID: 25388278
[TBL] [Abstract][Full Text] [Related]
60. [Possible functional role of the DD-domain of RNA-dependent polymerases].
Zavriev SK; Borisova OV
Mol Biol (Mosk); 1987; 21(1):229-41. PubMed ID: 2437438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
